Cargando…

Familial CD45RA(–) T cells to treat severe refractory infections in immunocompromised patients

BACKGROUND: Immunocompromised patients are susceptible to high-risk opportunistic infections and malignant diseases. Most antiviral and antifungal drugs are quite toxic, relatively ineffective, and induce resistance in the long term. The transfer of pathogen-specific Cytotoxic T-Lymphocytes has show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Akioui Sanz, Karima, Echecopar Parente, Carlos, Ferreras, Cristina, Menéndez Ribes, Marta, Navarro, Alfonso, Mestre, Carmen, Clares, Laura, Vicario, José Luis, Balas, Antonio, De Paz, Raquel, López Granados, Eduardo, Sánchez Zapardiel, Elena, Jiménez, Carlos, López-Oliva, María, Ramos, Esther, Hernández-Oliveros, Francisco, Pérez-Martínez, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944023/ https://www.ncbi.nlm.nih.gov/pubmed/36844219 http://dx.doi.org/10.3389/fmed.2023.1083215

Ejemplares similares

Donor selection for adoptive cell therapy with CD45RA(−) memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
por: Al-Akioui-Sanz, Karima, et al.
Publicado: (2023)

Cellular and Humoral Responses from Sars-Cov-2 Specific CD45RA- Memory T Cells from Convalescent and Naive Donors. Clinical Application As an Adoptive Cell Therapy for COVID-19
por: Sanz, Karima AL-Akioui, et al.
Publicado: (2022)

Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
por: Al-Akioui, K., et al.
Publicado: (2022)

Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
por: Mestre-Durán, Carmen, et al.
Publicado: (2023)

A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210)
por: Pérez-Martínez, Antonio, et al.
Publicado: (2021)

A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)
por: Perez, Antonio, et al.
Publicado: (2022)

A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)
por: Perez-Martinez, Antonio, et al.
Publicado: (2023)

A simple genotyping method for CD247 3′‐untranslated region polymorphism rs1052231 and characterization of a reference cell panel
por: Al‐Akioui‐Sanz, Karima, et al.
Publicado: (2021)

SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
por: Ferreras, C., et al.
Publicado: (2021)

Differential Expression of CD45RO and CD45RA in Bovine T Cells
por: Kandel, Anmol, et al.
Publicado: (2022)

Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3′‐untranslated regions
por: Asenjo, Judit, et al.
Publicado: (2022)

CD45RA and CD45RBhigh expression induced by thymic selection events
Publicado: (1992)

Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA
por: Tian, Yuan, et al.
Publicado: (2017)

Selective depletion of naïve T cells by targeting CD45RA
por: Naik, Swati, et al.
Publicado: (2023)

FCGR Genetic Variation in Two Populations From Ecuador Highlands—Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene
por: Moraru, Manuela, et al.
Publicado: (2021)

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.
por: Durán, C., et al.
Publicado: (2022)

CD45RA and CD45RO Are Regulated in a Cell-Type Specific Manner in Inflammation and Sepsis
por: Ahmed, Muhammad G. T., et al.
Publicado: (2023)

A phase I/II dose-escalation single center study to evaluate the safety of infusion of memory t cells as adoptive therapy in coronavirus pneumonia and /or lymphopenia (release)
por: Perez-Martinez, A., et al.
Publicado: (2021)

Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes
Publicado: (1994)

Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)

CD45RA, CD8β, and IFNγ Are Potential Immune Biomarkers of Human Cognitive Function
por: Esgalhado, André J., et al.
Publicado: (2020)

CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype
por: Trushin, Sergey A, et al.
Publicado: (2009)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

CD45RA(-)Foxp3(high) but not CD45RA(+)Foxp3(low) suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression
por: Sun, Wei, et al.
Publicado: (2014)

Submarine groundwater discharge data at meter scale ((223)Ra, (224)Ra, (226)Ra, (228)Ra and (222)Rn) in Indian River Bay (Delaware, US)
por: Duque, Carlos, et al.
Publicado: (2019)

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
por: Pérez-Martínez, A., et al.
Publicado: (2021)

A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2016)

Localization Algorithm with On-line Path Loss Estimation and Node Selection
por: Bel, Albert, et al.
Publicado: (2011)

Acyclovir-induced neurotoxicity in an immunocompromised patient
por: Marks, Daniel, et al.
Publicado: (2020)

Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
por: Ferreras, C., et al.
Publicado: (2023)

Decreased effector memory CD45RA(+ )CD62L(- )CD8(+ )T cells and increased central memory CD45RA(- )CD62L(+ )CD8(+ )T cells in peripheral blood of rheumatoid arthritis patients
por: Maldonado, Anastacia, et al.
Publicado: (2003)

Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4(+) and CD8(+) T cells in children with asthma
por: Machura, Edyta, et al.
Publicado: (2008)

Developing in vitro expanded CD45RA(+) regulatory T cells as an adoptive cell therapy for Crohn's disease
por: Canavan, James B, et al.
Publicado: (2016)

LoRaFarM: A LoRaWAN-Based Smart Farming Modular IoT Architecture
por: Codeluppi, Gaia, et al.
Publicado: (2020)

Secondary organising pneumonia to persistent SARS-CoV-2 infection in immunocompromised patient
por: Granados, Galo David, et al.
Publicado: (2022)

CD28-, CD45RA(null/dim) and natural killer-like CD8+ T cells are increased in peripheral blood of women with low-grade cervical lesions
por: Pita-Lopez, Maria Luisa, et al.
Publicado: (2014)

Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7(+)CD45RA(−) T Regulatory Cells
por: Gregson, Aric L., et al.
Publicado: (2010)

Unconventional CD45RA+ memory CD8 T cells to control HIV infection during antiretroviral therapy
por: Rolot, Marion, et al.
Publicado: (2020)

The clinical implication of CD45RA(+) naïve T cells and CD45RO(+) memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction
por: Hang, Junjie, et al.
Publicado: (2019)

A prognostic value of CD45RA(+), CD45RO(+), CCL20(+) and CCR6(+) expressing cells as ‘immunoscore’ to predict cervical cancer induced by HPV
por: Fernandes, Ana Teresa G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7n8rbhh4rooqhqt2q5p17lva1f